TRAW
Traws Pharma, Inc.
-0.00 (-0.36%)0.53USD39.0K成交股數8.1M市值–本益比(近四季)2.9股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 2.0M · 0.00 |
| 近 180 天 淨額 | 2.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | 04-28 | ORBIMED ADVISORS LLC | TenPercentOwner | P 公開市場買進 | 598K | 1.67 | 998K | 1.2M | SEC |
| 2026-04-16 | 04-28 | OrbiMed Capital GP VIII LLC | TenPercentOwner | P 公開市場買進 | 598K | 1.67 | 998K | 1.2M | SEC |
| 2025-12-12 | 04-08 | Parker Charles Nolan | Chief Financial Officer | A 獲配股票 | 15.4K | – | – | 15.4K | SEC |
| 2025-12-12 | 12-16 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 16.4K | – | – | 151K | SEC |
| 2025-12-12 | 12-16 | Redfield Robert | Chief Medical Officer | A 獲配股票 | 16.4K | – | – | 114K | SEC |
| 2025-12-12 | 12-16 | Pauza Charles David | Chief Science Officer Virology | A 獲配股票 | 18.5K | – | – | 116K | SEC |
| 2025-12-12 | 12-16 | Dukes Iain D. | Chief Executive Officer | A 獲配股票 | 36.9K | – | – | 171K | SEC |
| 2025-12-12 | 12-16 | CAUTREELS WERNER | Director | A 獲配股票 | 4.9K | – | – | 109K | SEC |
| 2025-12-12 | 12-16 | Clarke Trafford | Director | A 獲配股票 | 6.2K | – | – | 6.2K | SEC |
| 2025-12-12 | 12-16 | Shoemaker Mary Teresa | Director | A 獲配股票 | 6.2K | – | – | 6.3K | SEC |
| 2025-12-12 | 12-16 | STOVER JACK E | Director | A 獲配股票 | 6.2K | – | – | 6.2K | SEC |
| 2025-12-12 | 12-16 | Leaman John Harold | Director | A 獲配股票 | 4.1K | – | – | 4.1K | SEC |
| 2025-04-02 | 04-08 | TPAV, LLC | TenPercentOwner | J 其他 | 606K | – | – | 0 | SEC |
| 2025-04-02 | 04-08 | Savchuk Nikolay | Chief Operating Officer | J 其他 | 606K | – | – | 0 | SEC |
| 2025-02-18 | 02-19 | CAUTREELS WERNER | Chief Executive Officer | M 選擇權執行 | 96.3K | 0.01 | 963.48 | 104K | SEC |
| 2024-06-18 | 06-20 | Guerin Mark Patrick | CFO | F 繳稅扣股 | 2.2K | 0.47 | 1K | 39.3K | SEC |
| 2024-06-10 | 06-20 | Guerin Mark Patrick | CFO | M 選擇權執行 | 5.5K | – | – | 41.5K | SEC |
| 2024-04-01 | 08-07 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 67.5K | – | – | 134K | SEC |
| 2024-04-01 | 08-07 | Dukes Iain D. | Executive Chairman | A 獲配股票 | 67.5K | – | – | 134K | SEC |
| 2024-04-01 | 04-03 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 67.5K | – | – | 134K | SEC |
| 2024-04-01 | 04-03 | Dukes Iain D. | Executive Chairman | A 獲配股票 | 66.7K | – | – | 66.7K | SEC |
| 2024-04-01 | 04-03 | Redfield Robert | Acting Chief Medical Officer | A 獲配股票 | 97.5K | – | – | 97.5K | SEC |
| 2024-04-01 | 04-03 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 1.6M | – | – | 1.6M | SEC |
| 2024-04-01 | 04-03 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 886K | – | – | 886K | SEC |
| 2024-04-01 | 04-03 | Pauza Charles David | Chief Science Officer Virology | A 獲配股票 | 97.5K | – | – | 97.5K | SEC |
| 2024-04-01 | 04-03 | CAUTREELS WERNER | Chief Executive Officer | A 獲配股票 | 200K | – | – | 200K | SEC |
| 2024-04-01 | 04-03 | Savchuk Nikolay | Chief Operating Officer | A 獲配股票 | 66.7K | – | – | 66.7K | SEC |
| 2024-04-01 | 04-03 | Dukes Iain D. | Executive Chairman | A 獲配股票 | 1.6M | – | – | 1.6M | SEC |
| 2024-04-01 | 04-03 | Dukes Iain D. | Executive Chairman | A 獲配股票 | 67.5K | – | – | 134K | SEC |
| 2024-03-14 | 03-15 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F 繳稅扣股 | 8.7K | 0.90 | 8K | 74.8K | SEC |
| 2024-03-14 | 03-15 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 2.6K | 0.90 | 2K | 36.0K | SEC |
| 2024-03-13 | 03-15 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M 選擇權執行 | 23.1K | – | – | 83.5K | SEC |
| 2024-03-13 | 03-15 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 8.7K | – | – | 38.6K | SEC |
| 2024-02-07 | 02-09 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 6.9K | – | – | 32.3K | SEC |
| 2024-02-07 | 02-09 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F 繳稅扣股 | 9.2K | 0.67 | 6K | 60.4K | SEC |
| 2024-02-07 | 02-09 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M 選擇權執行 | 21.3K | – | – | 69.6K | SEC |
| 2024-02-07 | 02-09 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 2.4K | 0.67 | 2K | 29.9K | SEC |
| 2023-08-03 | 08-04 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 1.4K | 1.02 | 1K | 25.4K | SEC |
| 2023-08-03 | 08-04 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F 繳稅扣股 | 4.7K | 1.01 | 5K | 48.3K | SEC |
| 2023-08-02 | 08-04 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M 選擇權執行 | 12.6K | – | – | 53.0K | SEC |
| 2023-08-02 | 08-04 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 4.8K | – | – | 26.9K | SEC |
| 2023-06-12 | 06-13 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 1.6K | 1.14 | 2K | 22.1K | SEC |
| 2023-06-12 | 06-13 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 5.5K | – | – | 23.7K | SEC |
| 2023-02-07 | 02-08 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 6.9K | – | – | 20.0K | SEC |
| 2023-02-07 | 02-08 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F 繳稅扣股 | 7.0K | 1.36 | 9K | 40.5K | SEC |
| 2023-02-07 | 02-08 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M 選擇權執行 | 21.3K | – | – | 47.5K | SEC |
| 2023-02-07 | 02-08 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.2K | 1.36 | 2K | 10.5K | SEC |
| 2023-02-07 | 02-08 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M 選擇權執行 | 5.8K | – | – | 11.7K | SEC |
| 2023-02-07 | 02-08 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 1.8K | 1.36 | 2K | 18.2K | SEC |
| 2022-08-03 | 08-04 | Guerin Mark Patrick | CFO AND COO | F 繳稅扣股 | 1.4K | 1.32 | 2K | 13.1K | SEC |
| 2022-08-03 | 08-04 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | F 繳稅扣股 | 1.1K | 1.32 | 1K | 5.9K | SEC |
| 2022-08-03 | 08-04 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F 繳稅扣股 | 4.6K | 1.32 | 6K | 26.1K | SEC |
| 2022-08-02 | 08-04 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M 選擇權執行 | 12.6K | – | – | 30.7K | SEC |
| 2022-08-02 | 08-04 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M 選擇權執行 | 4.7K | – | – | 7.0K | SEC |
| 2022-08-02 | 08-04 | Guerin Mark Patrick | CFO AND COO | M 選擇權執行 | 4.8K | – | – | 14.4K | SEC |
| 2022-01-28 | 01-31 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 1.5K | 1.67 | 3K | 24.5K | SEC |
| 2022-01-21 | 01-24 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 1.5K | 2.02 | 3K | 23.0K | SEC |
| 2022-01-14 | 01-18 | OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | P 公開市場買進 | 1.5K | 2.20 | 3K | 21.5K | SEC |
| 2022-01-07 | 01-10 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 1.5K | 2.39 | 4K | 20.0K | SEC |
| 2021-11-19 | 11-23 | OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | P 公開市場買進 | 1.0K | 3.16 | 3K | 18.5K | SEC |
| 2021-11-18 | 11-19 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | X 選擇權履約 | 5.0K | 3.00 | 15K | 17.5K | SEC |
| 2021-09-28 | 09-29 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 2.4K | 4.20 | 10K | 12.5K | SEC |
| 2021-09-28 | 09-29 | Gelder Mark S. MD | Chief Medical Officer | P 公開市場買進 | 2.4K | 4.20 | 10K | 2.4K | SEC |
| 2021-09-28 | 09-28 | MARINO JAMES J | Director | P 公開市場買進 | 6.0K | 4.20 | 25K | 21.3K | SEC |
| 2021-09-28 | 09-28 | Fruchtman Steven M | President, Chief Executive Off | P 公開市場買進 | 2.4K | 4.20 | 10K | 18.1K | SEC |
| 2021-02-16 | 02-17 | Shoemaker Mary Teresa | Director | P 公開市場買進 | 13.0K | 1.00 | 13K | 50.7K | SEC |
| 2021-02-16 | 02-17 | MARINO JAMES J | Director | P 公開市場買進 | 25.0K | 1.00 | 25K | 231K | SEC |
| 2021-02-16 | 02-17 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 12.0K | 1.00 | 12K | 152K | SEC |
| 2021-02-16 | 02-17 | Guerin Mark Patrick | Chief Financial Officer | P 公開市場買進 | 15.0K | 1.00 | 15K | 145K | SEC |
| 2021-02-16 | 02-17 | Fruchtman Steven M | President, Chief Executive Off | P 公開市場買進 | 20.0K | 1.00 | 20K | 236K | SEC |
| 2020-12-11 | 12-14 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 30.0K | 0.32 | 10K | 140K | SEC |
| 2020-11-27 | 11-30 | Guerin Mark Patrick | Chief Financial Officer | P 公開市場買進 | 4.6K | 0.26 | 1K | 130K | SEC |
| 2020-11-25 | 11-30 | Guerin Mark Patrick | Chief Financial Officer | P 公開市場買進 | 16.8K | 0.26 | 4K | 126K | SEC |
| 2020-11-25 | 11-30 | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | P 公開市場買進 | 20.0K | 0.26 | 5K | 110K | SEC |
| 2020-11-25 | 11-30 | Fruchtman Steven M | President, Chief Executive Off | P 公開市場買進 | 40.0K | 0.26 | 10K | 216K | SEC |
| 2020-11-25 | 11-30 | Shoemaker Mary Teresa | Director | P 公開市場買進 | 37.7K | 0.27 | 10K | 37.7K | SEC |
| 2020-11-24 | 11-27 | MARINO JAMES J | Director | P 公開市場買進 | 38.8K | 0.26 | 10K | 206K | SEC |
| 2020-08-27 | 08-31 | Reddy E Premkumar | Director | S 公開市場賣出 | 528K | 0.27 | 143K | 16.7K | SEC |
| 2020-08-27 | 08-31 | Hoffman Michael B | Director | S 公開市場賣出 | 1.9K | 0.27 | 506.52 | 0 | SEC |
| 2020-08-27 | 08-31 | Hoffman Michael B | Director | S 公開市場賣出 | 182K | 0.27 | 49K | 21.9K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1.2M | 1.0M | 新進 | 新進 |
| Ally Bridge Group (NY) LLC | 786K | 663K | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 730K | 616K | 新進 | 新進 |
| ADAR1 Capital Management, LLC | 598K | 504K | 新進 | 新進 |
| Lynx1 Capital Management LP | 559K | 472K | 新進 | 新進 |
| Ikarian Capital, LLC | 478K | 403K | 新進 | 新進 |
| SPHERA FUNDS MANAGEMENT LTD. | 398K | 336K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 330K | 278K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 216K | 182K | 新進 | 新進 |
| Alyeska Investment Group, L.P. | 164K | 139K | 新進 | 新進 |
| BOOTHBAY FUND MANAGEMENT, LLC | 134K | 113K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 111K | 94K | 新進 | 新進 |
| Kynam Capital Management, LP | 84.4K | 71K | 新進 | 新進 |
| Dauntless Investment Group, LLC | 80.6K | 68K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 54.5K | 46K | 新進 | 新進 |
| NORTHERN TRUST CORP | 37.5K | 32K | 新進 | 新進 |
| STATE STREET CORP | 25.8K | 22K | 新進 | 新進 |
| XTX Topco Ltd | 18.1K | 15K | 新進 | 新進 |
| BlackRock, Inc. | 9.9K | 8K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 5.1K | 4K | 新進 | 新進 |
| HUNTINGTON NATIONAL BANK | 4.7K | 4K | 新進 | 新進 |
| UBS Group AG | 3.5K | 3K | 新進 | 新進 |
| BARCLAYS PLC | 1.9K | 2K | 新進 | 新進 |
| SBI Securities Co., Ltd. | 1.7K | 1K | 新進 | 新進 |
| Federation des caisses Desjardins du Quebec | 500 | 414.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 34 +6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 34 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 6.2M · 40.1% |
| 合計季末市值 | 5.1M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 633K |
|---|---|
| 與上期比 | +1.6% |
| 佔流通股數 | 4.12% |
| 日均成交量 | 105K |
| 回補天數 | 6.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 633K | +1.6% | 4.12% | 105K | 6.0 |
| 2026-08-14 | 624K | -0.5% | 4.06% | 97.6K | 6.4 |
| 2026-07-31 | 627K | -10.4% | 4.08% | 113K | 5.6 |
| 2026-07-15 | 700K | -28.6% | 4.55% | 183K | 3.8 |
| 2026-06-30 | 980K | -13.6% | 6.38% | 325K | 3.0 |
| 2026-06-15 | 1.1M | -17.5% | 7.38% | 700K | 1.6 |
| 2026-05-29 | 1.4M | -17.7% | 8.95% | 706K | 2.0 |
| 2026-05-15 | 1.7M | +198.4% | 10.88% | 10.8M | 1.0 |
| 2026-04-30 | 560K | +38.1% | 3.64% | 314K | 1.8 |
| 2026-04-15 | 406K | -1.5% | 2.64% | 198K | 2.1 |
| 2026-03-31 | 412K | -9.9% | 2.68% | 46.9K | 8.8 |
| 2026-03-13 | 457K | -12.2% | 2.97% | 105K | 4.4 |
| 2026-02-27 | 520K | -1.3% | 3.38% | 126K | 4.1 |
| 2026-02-13 | 527K | +4.1% | 3.43% | 135K | 3.9 |
| 2026-01-30 | 506K | -4.9% | 3.29% | 391K | 1.3 |
| 2026-01-15 | 532K | +106.1% | 3.46% | 355K | 1.5 |
| 2025-12-31 | 258K | +46.9% | 1.68% | 551K | 1.0 |
| 2025-12-15 | 176K | -39.8% | 1.14% | 200K | 1.0 |
| 2025-11-28 | 292K | +293.6% | 1.90% | 235K | 1.2 |
| 2025-11-14 | 74.1K | +37.0% | 0.48% | 923K | 1.0 |
| 2025-10-31 | 54.1K | -27.4% | 0.35% | 163K | 1.0 |
| 2025-10-15 | 74.5K | -44.7% | 0.48% | 391K | 1.0 |
| 2025-09-30 | 135K | +12.3% | 0.88% | 65.7K | 2.1 |
| 2025-09-15 | 120K | +16.9% | 0.78% | 114K | 1.1 |
| 2025-08-29 | 103K | -37.0% | 0.67% | 94.2K | 1.1 |
| 2025-08-15 | 163K | +68.6% | 1.06% | 187K | 1.0 |